Target intelligence / Profile preview

SLCO4A1 antisense RNA 1 (SLCO4A1-AS1)

Target
SLCO4A1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

SLCO4A1 antisense RNA 1 (SLCO4A1-AS1) is a long non-coding RNA (lncRNA) located on chromosome 20, transcribed antisense to the SLCO4A1 gene. It functions as a competing endogenous RNA (ceRNA), sequestering microRNAs and thereby modulating the expression of oncogenes such as IKKα and XIAP. SLCO4A1-AS1 is upregulated in multiple cancer types, including non-small cell lung cancer, gastric cancer, colorectal cancer, and bladder cancer, where it promotes tumor cell proliferation, migration, invasion, and inhibits apoptosis largely through modulation of pathways like NF-κB and by influencing apoptosis regulators. These findings suggest that SLCO4A1-AS1 represents a potential biomarker and novel therapeutic target in several oncologic contexts, although it is not currently associated with any approved drug therapies and research is at an early stage.

Other names
SLCO4A1-AS1LncRNA SLCO4A1-AS1
02

Mechanism of action

Acts as a molecular sponge for microRNAs (such as miR-223-3p in NSCLC and miR-149 in gastric cancer) to regulate target mRNA expression (such as IKKα or XIAP), thereby influencing signaling pathways (e.g., NF-κB). Post-transcriptional regulation of oncogenes via ceRNA network.

03

Biological functions

Regulation of cell proliferationRegulation of apoptosisRegulation of cell migrationRegulation of cell invasionRegulation of metastasisTranscriptional regulation (acts as a competing endogenous RNA or ceRNA)Other
04

Disease associations

CancerNon-small cell lung cancer (NSCLC)Gastric cancerColorectal cancerBladder cancerOther
05

Biomarkers

Potential biomarker for prognosis and treatment response in several cancers (notably NSCLC and gastric cancer)

Beyond the preview

Go deeper on SLCO4A1 antisense RNA 1 (SLCO4A1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLCO4A1 antisense RNA 1 (SLCO4A1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call